These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

471 related items for PubMed ID: 31977539

  • 1. CHA2DS2-VASc and SAMe-TT2R2 scores as predictors of recurrence for nonvalvular atrial fibrillation patients on vitamin K antagonists after radiofrequency catheter ablation.
    Zhao J, Zhou D, Chen M, Zhuo C, Lin Z, Zheng L, Wang Q.
    J Cardiovasc Med (Hagerstown); 2020 Mar; 21(3):200-208. PubMed ID: 31977539
    [Abstract] [Full Text] [Related]

  • 2. CHADS2 and CHA2DS2-VASc scores as predictors of left atrial ablation outcomes for paroxysmal atrial fibrillation.
    Letsas KP, Efremidis M, Giannopoulos G, Deftereos S, Lioni L, Korantzopoulos P, Vlachos K, Xydonas S, Kossyvakis C, Sideris A.
    Europace; 2014 Feb; 16(2):202-7. PubMed ID: 23813452
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. The impact of risk score (CHADS2 versus CHA2DS2-VASc) on long-term outcomes after atrial fibrillation ablation.
    Jacobs V, May HT, Bair TL, Crandall BG, Cutler M, Day JD, Weiss JP, Osborn JS, Muhlestein JB, Anderson JL, Mallender C, Bunch TJ.
    Heart Rhythm; 2015 Apr; 12(4):681-6. PubMed ID: 25546809
    [Abstract] [Full Text] [Related]

  • 5. Comparison of CHADS2, R2CHADS2, and CHA2DS2-VASc scores for the prediction of rhythm outcomes after catheter ablation of atrial fibrillation: the Leipzig Heart Center AF Ablation Registry.
    Kornej J, Hindricks G, Kosiuk J, Arya A, Sommer P, Husser D, Rolf S, Richter S, Huo Y, Piorkowski C, Bollmann A.
    Circ Arrhythm Electrophysiol; 2014 Apr; 7(2):281-7. PubMed ID: 24610790
    [Abstract] [Full Text] [Related]

  • 6. Renal dysfunction, stroke risk scores (CHADS2, CHA2DS2-VASc, and R2CHADS2), and the risk of thromboembolic events after catheter ablation of atrial fibrillation: the Leipzig Heart Center AF Ablation Registry.
    Kornej J, Hindricks G, Kosiuk J, Arya A, Sommer P, Husser D, Rolf S, Richter S, Piorkowski C, Gaspar T, Lip GY, Bollmann A.
    Circ Arrhythm Electrophysiol; 2013 Oct; 6(5):868-74. PubMed ID: 24047706
    [Abstract] [Full Text] [Related]

  • 7. Long-Term Stroke Risk Prediction in Patients With Atrial Fibrillation: Comparison of the ABC-Stroke and CHA2DS2-VASc Scores.
    Rivera-Caravaca JM, Roldán V, Esteve-Pastor MA, Valdés M, Vicente V, Lip GYH, Marín F.
    J Am Heart Assoc; 2017 Jul 20; 6(7):. PubMed ID: 28729407
    [Abstract] [Full Text] [Related]

  • 8. Comparison of CHADS2 and CHA2DS2-VASC anticoagulation recommendations: evaluation in a cohort of atrial fibrillation ablation patients.
    Winkle RA, Mead RH, Engel G, Kong MH, Patrawala RA.
    Europace; 2014 Feb 20; 16(2):195-201. PubMed ID: 24036378
    [Abstract] [Full Text] [Related]

  • 9. Stroke and Thromboembolism in Warfarin-Treated Patients with Atrial Fibrillation: Comparing the CHA2DS2-VASc and GARFIELD-AF Risk Scores.
    Proietti M, Rivera-Caravaca JM, Esteve-Pastor MA, Marín F, Lip GYH.
    Thromb Haemost; 2021 Aug 20; 121(8):1107-1114. PubMed ID: 33296920
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. CHA2DS2-VASc score and fibrinogen concentration in patients with atrial fibrillation.
    Semczuk-Kaczmarek K, Płatek AE, Ryś A, Adamowicz J, Legosz P, Kotkowski M, Dudzik-Płocica A, Gorko D, Szymański FM, Filipiak KJ.
    Adv Clin Exp Med; 2019 Nov 20; 28(11):1451-1457. PubMed ID: 31596555
    [Abstract] [Full Text] [Related]

  • 14. Patterns of Anticoagulation Use and Cardioembolic Risk After Catheter Ablation for Atrial Fibrillation.
    Noseworthy PA, Yao X, Deshmukh AJ, Van Houten H, Sangaralingham LR, Siontis KC, Piccini JP, Asirvatham SJ, Friedman PA, Packer DL, Gersh BJ, Shah ND.
    J Am Heart Assoc; 2015 Nov 05; 4(11):. PubMed ID: 26541393
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Assessment of Use vs Discontinuation of Oral Anticoagulation After Pulmonary Vein Isolation in Patients With Atrial Fibrillation.
    Själander S, Holmqvist F, Smith JG, Platonov PG, Kesek M, Svensson PJ, Blomström-Lundqvist C, Tabrizi F, Tapanainen J, Poci D, Jönsson A, Själander A.
    JAMA Cardiol; 2017 Feb 01; 2(2):146-152. PubMed ID: 27893055
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Uninterrupted administration of edoxaban vs vitamin K antagonists in patients undergoing atrial fibrillation catheter ablation: Rationale and design of the ELIMINATE-AF study.
    Hohnloser SH, Camm J, Cappato R, Diener HC, Heidbuchel H, Lanz HJ, Mont L, Morillo CA, Smolnik R, Yin OQP, Kautzner J.
    Clin Cardiol; 2018 Apr 01; 41(4):440-449. PubMed ID: 29663464
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.